FASSI, ENRICO MARIO ALESSANDRO
FASSI, ENRICO MARIO ALESSANDRO
Dipartimento di Scienze Farmaceutiche
Analysis of Hsp90 allosteric modulators interactome reveals a potential dual action mode involving mitochondrial MDH2
2021 C. Cassiano, E. Morretta, M. Costantini, E.M.A. Fassi, G. Colombo, S. Sattin, A. Casapullo
Computational Design and Biological Evaluation of Analogs of Lupin Peptide P5 Endowed with Dual PCSK9/HMG-CoAR Inhibiting Activity
2022 C. Lammi, E. Fassi, J. Li, M. Bartolomei, G. Benigno, G. Roda, A. Arnoldi, G. Grazioso
COMPUTATIONAL DESIGN OF PEPTIDES AND PEPTIDOMIMETICS AS POTENTIAL THERAPEUTIC AGENTS TO SATISFY PRESSING MEDICAL NEEDS
2023 E.M.A. Fassi
Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 Mpro Inhibitors
2023 E.M.A. Fassi, M. Manenti, A. Citarella, M. Dei Cas, S. Casati, N. Micale, T. Schirmeister, G. Roda, A. Silvani, G. Grazioso
Development of AMBER Parameters for Molecular Simulations of Selected Boron-Based Covalent Ligands
2023 M.A. Chiacchio, L. Legnani, E.M.A. Fassi, G. Roda, G. Grazioso
Elagolix analogues as potential new GnRH antagonists
2022 S. Ciceri, D. Colombo, E. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Elagolix analogues as potential new GnRH antagonists: design, synthesis and characterization
2022 S. Ciceri, D. Colombo, E. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
2023 S. Ciceri, D.R. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, M. Iannone, C. Castellano, F. Meneghetti
Elucidating the 3D Structure of a Surface Membrane Antigen from Trypanosoma cruzi as a Serodiagnostic Biomarker of Chagas Disease
2022 F. Di Pisa, S. De Benedetti, E.M.A. Fassi, M. Bombaci, R. Grifantini, A. Musico, R. Frigerio, A. Pontillo, C. Rigo, S. Abelli, R. Grande, N. Zanchetta, D. Mileto, A. Mancon, A. Rizzo, A. Gori, M. Cretich, G. Colombo, M. Bolognesi, L.J. Gourlay
Exploring Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Autoproteolysis Process by Molecular Simulations: Hints for Drug Design
2020 J. Sgrignani, E.M.A. Fassi, C. Lammi, G. Roda, G. Grazioso
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity
2022 E.M.A. Fassi, M. Garofalo, J. Sgrignani, M.V. DEI CAS, M. Mori, G. Roda, A. Cavalli, G. Grazioso
Investigation of Chlorella pyrenoidosa Protein as a Source of Novel Angiotensin I-Converting Enzyme (ACE) and Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides
2021 Y. Li, G. Aiello, E.M.A. Fassi, G. Boschin, M. Bartolomei, C. Bollati, G. Roda, A. Arnoldi, G. Grazioso, C. Lammi
Natural compounds targeting E. Coli WRBA as antibiofilm agents: Virtual screening, design and synthesis of analogs, biological evaluation
2022 S. Villa, M. Mori, I.A. Ratt, F. Meneghetti, G. Roda, A. Gelain, F. Villa, E. Fassi, F. Forlani, G. Grazioso
Oxidation State Dependent Conformational Changes of HMGB1 Regulate the Formation of the CXCL12/HMGB1 Heterocomplex
2019 E.M.A. Fassi, J. Sgrignani, G. D'Agostino, V. Cecchinato, M. Garofalo, G. Grazioso, M. Uguccioni, A. Cavalli
Structure, Immunoreactivity, and In Silico Epitope Determination of {SmSPI} S. mansoni Serpin for Immunodiagnostic Application
2021 S. De Benedetti, F. Di Pisa, E.M.A. Fassi, M. Cretich, A. Music(`(o)), R. Frigerio, A. Mussida, M. Bombaci, R. Grifantini, G. Colombo, M. Bolognesi, R. Grande, N. Zanchetta, M.R. Gismondo, D. Mileto, A. Mancon, L.J. Gourlay
Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction
2021 J. Sgrignani, V. Cecchinato, E.M.A. Fassi, G. D'Agostino, M. Garofalo, G. Danelon, M. Pedotti, L. Simonelli, L. Varani, G. Grazioso, M. Uguccioni, A. Cavalli
Trans-Epithelial Transport, Metabolism and Biological Activity Assessment of the Multi-Target Lupin Peptide LILPKHSDAD (P5) and Its Metabolite LPKHSDAD (P5-Met)
2021 C. Lammi, G. Aiello, C. Bollati, J. Li, M. Bartolomei, G. Ranaldi, S. Ferruzza, E.M.A. Fassi, G. Grazioso, Y. Sambuy, A. Arnoldi